Feature Stories
-
Targeting Tumors: A New Strategy for Prostate Cancer Treatment
Weizmann scientists are fighting prostate cancer by combining chlorophyll and light. This powerful treatment may work for other cancers, too.
-
Tiny RNA Molecules Have a Big Role in Disease
February 2010
For years, it was thought that tiny microRNAs did not have an important function. Now, Dr. Eran Hornstein has found that they actually play a key role in helping to...
-
p53 and Personalized Medicine
January 2010
As a postdoctoral researcher at the Massachusetts Institute of Technology (MIT) 30 years ago, Prof. Varda Rotter was among the first scientists to study a little-known gene called p53. “We didn’t know then that it...
-
Tubes with a Twist
New type of nanotube made of gold and silver discovered at the Weizmann Institute of Science.
-
Sensing Material Defects
Material failure is a grave concern in man-made structures. Engineers have devised a battery of tests to prevent sudden failure by prior detection of material fatigue.
-
To Die for the Cause
Prof. Abraham Amsterdam studies the role of cell suicide in both normal and cancerous ovarian cells.
-
Don't Bury It, Recycle It!
Short-term solutions to carbon dioxide emissions, a main culprit in global warming, include such schemes as burying carbon dioxide from smokestacks deep in the ground...
-
Conference for Top Students
Prof. David Cahen, selected 24 of the nations top Ph.D. students in the physical, life and engineering sciences and invited them to spend five days with 20 Israeli and...
-
The Cancer Killer
Weizmann scientists have for years been studying the p53, the most "glamorous" of all tumor suppressor genes. They were the first to clone it.